NK:IO
About:
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.
Website: https://nk-io.com
Top Investors: Future Planet Capital, Innovate UK, Parkwalk Advisors, UK Innovation & Science Seed Fund, Meltwind Advisory
Description:
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy. The company develops both cell therapy and small molecule therapeutics primarily targeting cancer.
Total Funding Amount:
2.8M GBP
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
London, England, United Kingdom
Founded Date:
2020-01-01
Founders:
Hugh JM Brady, Matthew Fuchter, Mike Romanos
Number of Employees:
1-10
Last Funding Date:
2023-07-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai